Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics

Search Results for: COVID-19

March 14, 2022 Intelligence: Late-Breaking Lab News

Telehealth proved to be popular with Medicare patients during the SARS-CoV-2 pandemic. The federal U.S. Department of Health and Human Services (HHS) reported telehealth visits for Medicare beneficiaries increased in 2020 by an incredible 63 times—from approximately 840,000 in 2019 to 52.7 million! Federal health officials said in a news release that these figures will …

March 14, 2022 Intelligence: Late-Breaking Lab News Read More »

To access this post, you must purchase The Dark Report.

Labcorp to Buy Outreach, Manage Ascension Labs

CEO SUMMARY: In a blockbuster deal valued at almost half a billion dollars, Labcorp will manage dozens of hospital labs in 10 states on behalf of Ascension Health, one of the biggest health systems in the country. Labcorp will also spend $400 million to acquire certain assets of Ascension’s outreach laboratory services. Labcorp’s CEO characterized …

Labcorp to Buy Outreach, Manage Ascension Labs Read More »

To access this post, you must purchase The Dark Report.

Labs Should Be Cautious about ‘Surprising’ EKRA Ruling

CONFUSION ABOUT WHEN IT IS LEGAL UNDER TWO FEDERAL LAWS to pay commissions to sales reps based on volume and/or revenue has existed since the passage of the federal Eliminating Kickbacks in Recovery Act of 2018 (EKRA). Now, a district court judge in Hawaii has surprisingly ruled that payments of percentage-based sales commissions to clinical …

Labs Should Be Cautious about ‘Surprising’ EKRA Ruling Read More »

To access this post, you must purchase The Dark Report.

February 22, 2022 Intelligence: Late-Breaking Lab News

Scopio Labs, a medical imaging company in Tel Aviv, recently landed $50 million in Series C venture capital funding as it moves to more fully enter the clinical laboratory market, TechCrunch reported on Feb. 9. Scopio has developed a scanner that can magnify a whole blood sample by 100 times. The digital imaging system provides …

February 22, 2022 Intelligence: Late-Breaking Lab News Read More »

To access this post, you must purchase The Dark Report.

Non-COVID Part B Lab Spend Declined by 15.9% in 2020

MEDICARE PART B CLINICAL LABORATORY FEE SCHEDULE CUTS mandated by PAMA continue to bite deeply. A new government report shows that during fiscal 2020, the Medicare program spent 15.9% less for lab tests, when COVID-19 test payments are excluded.  The federal Department of Health and Human Services Office of Inspector General (OIG) recently released a …

Non-COVID Part B Lab Spend Declined by 15.9% in 2020 Read More »

To access this post, you must purchase The Dark Report.

Newsmaker Interview

  “Some services that have transitioned to retail pharmacies may essentially bring clinical labs closer to the consumer, which I don’t think labs truly appreciated since they traditionally have not had much direct access to the consumer.” —Lâle White, CEO, XIFIN  CEO SUMMARY: When XIFIN purchased OmniSYS, it put an exclamation point on the growing …

Newsmaker Interview Read More »

To access this post, you must purchase The Dark Report.

Labs Can Team with Employers to Improve Worker Productivity

HEALTHCARE’S ONGOING TRANSFORMATION AND THE EMPHASIS ON VALUE-BASED REIMBURSEMENT are creating a new opportunity for savvy clinical laboratory executives and pathologists. This opportunity is centered around the need of self-insured employers to address the problem of employee presenteeism.  “Helping employers with presenteeism can create a value stream for clinical laboratories,” says Kristine Bordenave, MD, FACP, …

Labs Can Team with Employers to Improve Worker Productivity Read More »

To access this post, you must purchase The Dark Report.

January 31, 2022 Intelligence: Late-Breaking Lab News

DNA-based breast cancer testing is taking a step forward. Illumina in San Diego, which sells next-generation sequencing (NGS) technology, announced a partnership with Agendia in Irvine, Calif., to develop in vitro diagnostic tests for oncology. Agendia offers proprietary breast cancer tests. The companies expect Agendia’s MammaPrint test to become the first decentralized, NGS-based breast cancer risk …

January 31, 2022 Intelligence: Late-Breaking Lab News Read More »

To access this post, you must purchase The Dark Report.

XIFIN’s Acquisition of OmniSYS Will Unite Lab with Pharmacy

This is an excerpt of a 1,829-word article in the January 10, 2022 issue of  THE DARK REPORT (TDR). The full article is available to members of The Dark Intelligence Group. CEO SUMMARY: XIFIN’s acquisition of OmniSys, a pharmacy technology company, is the latest evidence that retail pharmacies are preparing to become a new front …

XIFIN’s Acquisition of OmniSYS Will Unite Lab with Pharmacy Read More »

To access this post, you must purchase The Dark Report.

2021 Closes with Two Major Lab Industry Events

Normally, the time around Christmas and New Year passes quietly, typically without any significant developments. Such was not the case for the clinical laboratory industry in the last month of 2021 because of two announcements, each of which confirms ongoing market trends in healthcare and the lab testing industry.  The first announcement was on Dec. …

2021 Closes with Two Major Lab Industry Events Read More »

To access this post, you must purchase The Dark Report.

;